Abstract:Key PointsIn contrast to all other known prolyl isomerases, PIN1 has the unique property of binding to and catalysing the conversion of specific proline-directed serine/threonine phosphorylation motifs between the two distinct cis and trans conformations of proline. Such PIN1-catalysed prolyl isomerization functions as a molecular timer that modulates many targets at various steps of a given cellular process to synchronously control the amplitude and duration of a given cellular response or process.PIN1 is tightly regulated under physiological conditions, but is commonly overexpressed and/or overactivated in most human cancers, with its levels being correlated with clinical outcome in many cancers. By contrast, PIN1 polymorphisms that lower PIN1 expression are associated with reduced risk for multiple cancers.Pin1-null mice, which develop normally, are highly resistant to tumorigenesis even after overexpression of oncogenes or ablation of tumour suppressors. Conversely, PIN1 overexpression disrupts cell cycle coordination and leads to chromosome instability and tumorigenesis.Abnormal PIN1 activation disrupts the balance in cancer to activate at least 40 oncogenes and inactivate at least 20 tumour suppressors, many of which have a known role in cancer stem cells (CSCs).PIN1 inhibitors have the promising and desirable property of restoring the balance in cancer by simultaneously blocking many cancer-driving pathways in cancer cells and CSCs for treating aggressive and drug-resistant cancers. PIN1 is a major target of the drug all-trans retinoic acid (ATRA) in acute promyelocytic leukaemia.The recent development of cis and trans conformation-specific antibodies provides direct evidence for conformation-specific function and regulation by PIN1, and should facilitate the discovery of novel disease mechanisms and potential new therapies for PIN1-related diseases. Further development of conformation-specific antibodies against oncogenes and tumour suppressors that are PIN1 substrates would provide powerful tools for studying cancer signalling and may lead to new cancer diagnostics and/or therapeutics.

The Prolyl Isomerase Pin1 is A Regulator of P53 in Genotoxic Response

The Prolyl Isomerase Pin1 Is A Regulator Of P53 In Genotoxic Response (Vol 419, Pg 849, 2002)

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Prolyl Isomerase Pin1 in Cancer.

Prolyl isomerase Pin1: a promoter of cancer and a target for therapy

Prolyl isomerase Pin1 plays a dual role in cell proliferation and apoptosis by isomerizing orphan receptor TR3

Peptidyl-prolyl Cis/trans Isomerase Pin1 is Critical for the Regulation of PKB/Akt Stability and Activation Phosphorylation

1 POLYCOMB GROUP PROTEIN PHF 1 REGULATES P 53-DEPENDENT CELL GROWTH ARREST AND APOPTOSIS

Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis

The DNA-binding and Transcription-Activation Abilities of P53 Are Necessary but Not Sufficient for Its Antiproliferation Function.

Peptidyl-prolyl cis|[sol]|trans isomerase Pin1 is critical for the regulation of PKB|[sol]|Akt stability and activation phosphorylation

The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target

Pinning Down the Transcription: A Role for Peptidyl-Prolyl cis-trans Isomerase Pin1 in Gene Expression

PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage

Protein Phosphatase 5 and the Tumor Suppressor P53 Down-Regulate Each Other's Activities in Mice

Pin1 inhibits PP2A-mediated Rb dephosphorylation in regulation of cell cycle and S-phase DNA damage

p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice

Polycomb Group Protein PHF1 Regulates P53-Dependent Cell Growth Arrest and Apoptosis

Supplementary Figure 5 from Ribosomal Protein S27-like, a P53-Inducible Modulator of Cell Fate in Response to Genotoxic Stress

PD-L1 regulates genomic stability via interaction with cohesin-SA1 in the nucleus

Protein Phosphatase 1 Inhibits P53 Signaling by Dephosphorylating and Stabilizing Mdmx